| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 138, Issue 3 908-913, Copyright © 1987 by American Association of Immunologists
ARTICLES |
DL Sacks, SL Lal, SN Shrivastava, J Blackwell and FA Neva
The inability of most untreated patients with Kala-azar to control their visceral infections with Leishmania donovani has been attributed to a defective cell-mediated immune response to leishmanial antigens. We examined the in vitro response of T cells, including Leu-2+-depleted T cell populations, to determine whether unresponsiveness could be reversed. These studies on patients with visceral leishmaniasis in Bihar, north India, support previous observations regarding T cell unresponsiveness in patients with active disease: it is profound, it is specific, and it is reversible after successful chemotherapy. However, these studies also indicate that the specific unresponsiveness cannot be reversed by depletion of "suppressor" Leu-2+ T lymphocytes, nor by the addition of exogenously supplied human IL 2 to the cultures. One interpretation of these results is that in active cases of Kala-azar, there is an absence of Leishmania-specific T cells in the periphery. The possibility that reactive cells can be found in situ cannot be excluded. The observation that 13 of 25 family members of active cases were able respond to L. donovani in vitro or by skin testing suggests that the frequency of infection within an endemic area in Bihar is very high, and that assays for T cell responsiveness are far better epidemiologic tools for the detection of asymptomatic infection than is ELISA. Identification of such an exposed, Kala-azar-resistant population will be required to study host factors which influence the development of disease in infected individuals.
This article has been cited by other articles:
|
|
 |
|
  N. Kimblin, N. Peters, A. Debrabant, N. Secundino, J. Egen, P. Lawyer, M. P. Fay, S. Kamhawi, and D. Sacks Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies PNAS, July 22, 2008; 105(29): 10125 - 10130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nylen, R. Maurya, L. Eidsmo, K. D. Manandhar, S. Sundar, and D. Sacks Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis J. Exp. Med., April 16, 2007; 204(4): 805 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chakraborty, S. Banerjee, A. Sen, K. K. Banerjee, P. Das, and S. Roy Leishmania donovani Affects Antigen Presentation of Macrophage by Disrupting Lipid Rafts J. Immunol., September 1, 2005; 175(5): 3214 - 3224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ravindran, K. Anam, B. C. Bairagi, B. Saha, N. Pramanik, S. K. Guha, R. P. Goswami, D. Banerjee, and N. Ali Characterization of Immunoglobulin G and Its Subclass Response to Indian Kala-Azar Infection before and after Chemotherapy Infect. Immun., February 1, 2004; 72(2): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mookerjee, P. C. Sen, and A. C. Ghose Immunosuppression in Hamsters with Progressive Visceral Leishmaniasis Is Associated with an Impairment of Protein Kinase C Activity in Their Lymphocytes That Can Be Partially Reversed by Okadaic Acid or Anti-Transforming Growth Factor {beta} Antibody Infect. Immun., May 1, 2003; 71(5): 2439 - 2446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kumar, K. Pai, K. Pathak, and S. Sundar Enzyme-Linked Immunosorbent Assay for Recombinant K39 Antigen in Diagnosis and Prognosis of Indian Visceral Leishmaniasis Clin. Vaccine Immunol., November 1, 2001; 8(6): 1220 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Handman Leishmaniasis: Current Status of Vaccine Development Clin. Microbiol. Rev., April 1, 2001; 14(2): 229 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Probst, E. Stromberg, H. W. Ghalib, M. Mozel, R. Badaro, S. G. Reed, and J. R. Webb Identification and Characterization of T Cell-Stimulating Antigens from Leishmania by CD4 T Cell Expression Cloning J. Immunol., January 1, 2001; 166(1): 498 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Suffia, B. Ferrua, X. Stien, B. Mograbi, P. Marty, D. Rousseau, K. Fragaki, and J. Kubar A Novel Leishmania infantum Recombinant Antigen Which Elicits Interleukin 10 Production by Peripheral Blood Mononuclear Cells of Patients with Visceral Leishmaniasis Infect. Immun., February 1, 2000; 68(2): 630 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Anam, F. Afrin, D. Banerjee, N. Pramanik, S. K. Guha, R. P. Goswami, S. K. Saha, and N. Ali Differential Decline in Leishmania Membrane Antigen-Specific Immunoglobulin G (IgG), IgM, IgE, and IgG Subclass Antibodies in Indian Kala-Azar Patients after Chemotherapy Infect. Immun., December 1, 1999; 67(12): 6663 - 6669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pinelli, V. P. M. G. Rutten, M. Bruysters, P. F. Moore, and E. J. Ruitenberg Compensation for Decreased Expression of B7 Molecules on Leishmania infantum-Infected Canine Macrophages Results in Restoration of Parasite-Specific T-Cell Proliferation and Gamma Interferon Production Infect. Immun., January 1, 1999; 67(1): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Webb, A. Campos-Neto, P. J. Ovendale, T. I. Martin, E. J. Stromberg, R. Badaro, and S. G. Reed Human and Murine Immune Responses to a Novel Leishmania major Recombinant Protein Encoded by Members of a Multicopy Gene Family Infect. Immun., July 1, 1998; 66(7): 3279 - 3289. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
